Loading clinical trials...
Loading clinical trials...
Weight Management Plus Levonorgestrel Intrauterine System or Megestrol Acetate in Endometrial Atypical Hyperplasia: Multiple Single-arm, Prospective and Open-label Clinical Study
Conditions
Interventions
Intensive Lifestyle Intervention (ILI)
Megestrol Acetate 160 MG Oral Tablet
+1 more
Locations
1
China
Obstetrics and Gynecology Hospital of Fudan University
Shanghai, China
Start Date
June 13, 2022
Primary Completion Date
February 28, 2026
Completion Date
February 28, 2027
Last Updated
August 11, 2025
NCT06277232
NCT07395973
NCT06043609
NCT06387498
NCT05316935
NCT05316467
Lead Sponsor
Xiaojun Chen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions